Recombinant avipoxvirus
US5286639A · kind A · utility
5Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 1991 |
| Grant date | Feb 15, 1994 |
| Priority date | — |
| Expiry date | Feb 8, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A recombinant Avipoxvirus having inserted all or a part of cDNA coding for Newcastle disease virus-derived hemagglutinin neuraminidase in a genome region non-essential to proliferation of Avipoxvirus is provided. The recombinant Avipoxvirus is utilizable as vaccine for fowl.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.